SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels

BACKGROUND: Cardiovascular calcification (CVC) is a major concern in hemodialysis (HD) and the loss of endogenous modulators of calcification seems involved in the process. Phytate is an endogenous crystallization inhibitor and its low molecular mass and high water solubility make it potentially dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Perelló, Joan, Gómez, M., Ferrer, M. D., Rodríguez, N. Y., Salcedo, C., Buades, J. M., Pérez, M. M., Torregrosa, J. V., Martín, E., Maduell, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829128/
https://www.ncbi.nlm.nih.gov/pubmed/29350348
http://dx.doi.org/10.1007/s40620-018-0471-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829128/
https://www.ncbi.nlm.nih.gov/pubmed/29350348
http://dx.doi.org/10.1007/s40620-018-0471-9

Ejemplares similares